Elie Traer

Assistant Professor

  • 1077 Citations
  • 14 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Elie Traer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Mutation Medicine & Life Sciences
Fibroblast Growth Factor 2 Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Exosomes Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Mesenchymal Stromal Cells Medicine & Life Sciences
Organism Cloning Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 1077 Citations
  • 14 h-Index
  • 30 Article
  • 1 Comment/debate
Open Access
Myelodysplastic Syndromes
Homologous Transplantation
Acute Myeloid Leukemia
Hematopoietic Stem Cell Transplantation
Transplantation

Erratum: Correction: FGF2-FGFR1 signaling regulates release of leukemia-protective exosomes from bone marrow stromal cells (eLife (2019) 8 PII: e47174)

Javidi-Sharifi, N., Martinez, J., English, I., Joshi, S. K., Scopim-Ribeiro, R., Viola, S. K., Edwards, D. K., Agarwal, A., Lopez, C., Jorgens, D., Tyner, J., Druker, B. & Traer, E., Mar 29 2019, In : eLife. 8

Research output: Contribution to journalComment/debate

Open Access
Exosomes
Fibroblast Growth Factor 2
Mesenchymal Stromal Cells
Medicine
Bone

FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells

Javidi-Sharifi, N., Martinez, J., English, I., Joshi, S. K., Scopim-Ribiero, R., Edwards, D. K., Agarwal, A., Lopez, C., Jorgens, D., Tyner, J., Druker, B. & Traer, E., Feb 5 2019, In : eLife. 8

Research output: Contribution to journalArticle

Open Access
Exosomes
Fibroblast Growth Factor 2
Mesenchymal Stromal Cells
Protein-Tyrosine Kinases
Bone
1 Citation (Scopus)

Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study

Garcia-Manero, G., Abaza, Y., Takahashi, K., Medeiros, B. C., Arellano, M., Khaled, S. K., Patnaik, M., Odenike, O., Sayar, H., Tummala, M., Patel, P., Maness-Harris, L., Stuart, R., Traer, E., Karamlou, K., Yacoub, A., Ghalie, R., Giorgino, R. & Atallah, E., Feb 26 2019, In : Blood advances. 3, 4, p. 508-518 11 p.

Research output: Contribution to journalArticle

Azacitidine
Acute Myeloid Leukemia
Disease-Free Survival
Leukemia
Confidence Intervals

The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML

Dunlap, J., Leonard, J., Rosenberg, M., Cook, R., Press, R., Fan, G., Raess, P., Druker, B. & Traer, E., Aug 1 2019, In : American Journal of Hematology. 94, 8, p. 913-920 8 p.

Research output: Contribution to journalArticle

Open Access
Acute Myeloid Leukemia
Mutation
Survival
Recurrence
Insertional Mutagenesis